Compare PCRX & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | HRTG |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 898.0M |
| IPO Year | 2011 | 2014 |
| Metric | PCRX | HRTG |
|---|---|---|
| Price | $26.23 | $29.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $32.86 | $32.50 |
| AVG Volume (30 Days) | ★ 723.2K | 413.4K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 98.61 |
| EPS | 0.47 | ★ 4.83 |
| Revenue | $716,791,000.00 | ★ $842,277,000.00 |
| Revenue This Year | $6.24 | $5.45 |
| Revenue Next Year | $9.53 | $7.27 |
| P/E Ratio | $55.78 | ★ $6.02 |
| Revenue Growth | 3.14 | ★ 6.12 |
| 52 Week Low | $18.17 | $9.89 |
| 52 Week High | $27.64 | $31.98 |
| Indicator | PCRX | HRTG |
|---|---|---|
| Relative Strength Index (RSI) | 67.86 | 56.20 |
| Support Level | $25.17 | $27.40 |
| Resistance Level | $24.81 | $30.06 |
| Average True Range (ATR) | 0.96 | 1.06 |
| MACD | 0.26 | 0.00 |
| Stochastic Oscillator | 76.49 | 76.91 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.